SCHEMBL7078489

SCHEMBL7078489

C=Cc1cc2c(cc1Cc1cc[nH]n1)C(C)(C)CCC2(C)C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RXRA P19793 7/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8906014 0.74 RXRA (0.44) RXRA
SCHEMBL8906045 0.67 RXRA (0.40) RXRA
SCHEMBL8905381 0.67 RXRA (0.40) RXRA
SCHEMBL4711568 0.65 MEN1 (0.35) RXRA
SCHEMBL7195771 0.65 RARG (0.48) RXRA
SCHEMBL4588217 0.63
SCHEMBL4668056 0.61 RXRA (0.52) RXRA
SCHEMBL11654659 0.61 RXRA (0.37) RXRA
SCHEMBL11599145 0.61 RXRA (0.42) RXRA
SCHEMBL9117387 0.60 RARG (0.43) RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1324970-A2 RETINOIDS FOR THE TREATMENT OF EMPHYSEMA F. HOFFMANN-LA ROCHE AG (CH) 2003-07-09 EP disclosed
WO-2002028810-A2 RETINOIDS FOR THE TREATMENT OF EMPHYSEMA F. HOFFMANN-LA ROCHE AG (CH) 2002-04-11 WO disclosed